The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Workforce
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Calcineurin Inhibitor Pain Syndrome: A Case Report & Literature Review

Calcineurin Inhibitor Pain Syndrome: A Case Report & Literature Review

March 18, 2019 • By Priyanka Iyer, MD, MPH

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Figure 4: Bone Scan

Figure 4: Bone Scan
The bone scan showed increased bilateral symmetric uptake in the patient’s knees and ankles.

The exact pathogenesis of CIPS is not clearly defined. However, CNIs cause increased vascular changes that disrupt bone perfusion and permeability. This leads to intraosseous vasoconstriction and bone marrow edema, which causes pain. It is also postulated that CNI use results in facilitation of pro-nociceptive processes by interrupting glial function and by inhibition of nuclear factor-activated T cells.14

You Might Also Like
  • Cancer-Associated Myositis: A Case Report & Review of the Literature
  • Fellows’ Forum Case Report: Palmar Fasciitis & Polyarthritis Syndrome
  • Rheumatology Case Report: TINU Syndrome with Concomitant Synovitis
Explore This Issue
March 2019

Calcineurin regulates two-pore-domain potassium channels (K2Ps), which influence neuronal excitability and maintain resting membrane potentials, serving an important role in nociceptive regulation. The inhibition of calcineurin removes the regulation of these K2Ps, leading to enhanced neuronal excitability.14

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The most effective treatment of CIPS is modification of the immunosuppressive regimen, either with the use of a non-calcineurin agent or with close monitoring of CNI levels and adjustment of the dose (as was done in this patient).2 Extremity elevation is also advised.2

Therapy adjuncts include calcium channel blockers, such as nifedipine; GABA analogs, such as pregabalin; and bisphosphonates, such as IV pamidronate.3,15 Controversy exists regarding the usefulness of adjunctive therapies, although improvement in patient-reported symptoms have been observed in several case reports and series. CIPS is usually completely reversible over a period of months, without long-term sequelae.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

With a steady increase in the number of recipients of organ and hematopoietic stem cell transplants and, hence, more prevalent CNI use, this otherwise uncommon diagnosis is important to recognize. If identified early, cessation of CNIs in favor of an alternate immunosuppressive agent (or modification of the dose of CNI) is recommended, and musculoskeletal symptoms often quickly abate.


Priyanka Iyer, MD, MPH, is a second-year fellow in adult rheumatology at the University of Iowa, Iowa City.

Acknowledgment

The author would like to extend special thanks to Brittany Bettendorf, MD, who was an integral part of the treatment team and helped establish a unifying diagnosis.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

References

  1. Adwan MH. An update on drug-induced arthritis. Rheumatol Int. 2016 Aug;36(8):1089–1097.
  2. Grotz WH, Breitenfeldt MK, Braune SW, et al. Calcineurin-inhibitor induced pain syndrome (CIPS): A severe disabling complication after organ transplantation. Transpl Int. 2001;14(1):16–23.
  3. Elder GJ. From marrow oedema to osteonecrosis: Common paths in the development of post-transplant bone pain. Nephrology (Carlton). 2006 Dec;11(6):560–567.
  4. Lucas VP, Ponge TD, Plougastel-Lucas ML, et al. Musculoskeletal pain in renal-transplant recipients. N Engl J Med. 1991 Nov 14;325(20):1449–1450.
  5. Stevens JM, Hilson AJ, Sweny P. Post-renal transplant distal limb bone pain. An under-recognized complication of transplantation distinct from avascular necrosis of bone? Transplantation. 1995 Aug 15;60(3):305–307.
  6. Lawson CA, Fraser A, Veale DJ, Emery P. Cyclosporin treatment in psoriatic arthritis: A cause of severe leg pain. Ann Rheum Dis. 2003 May;62(5):489.
  7. Maeshima K, Ishii K, Horita M, et al. [Calcineurin-inhibitor induced pain syndrome (CIPS) in an adult-onset Still’s disease patient]. Nihon Naika Gakkai Zasshi. 2008 Nov 10;97(11):2782–2784.
  8. Isaacs KL. Severe bone pain as an adverse effect of cyclosporin therapy for Crohn’s disease. Inflamm Bowel Dis. 1998 May;4(2):95–97.
  9. Rahman AH, O’Brien C, Patchett SE. Leg bone pain syndrome in a patient with ulcerative colitis treated with cyclosporin. Ir J Med Sci. 2007 Jul–Sep;176(2):129–131.
  10. Tillmann FP, Jager M, Blondin D, et al. Post-transplant distal limb syndrome: Clinical diagnosis and long-term outcome in 37 renal transplant recipients. Transpl Int. 2008 Jun;21(6):547–553.
  11. Collini A, De Bartolomeis C, Barni R, et al. Calcineurin-inhibitor induced pain syndrome after organ transplantation. Kidney Int. 2006 Oct;70(7):1367–1370.
  12. Villaverde V, Cantalejo M, Balsa A, Mola EM. Leg bone pain syndrome in a kidney transplant patient treated with tacrolimus (FK506). Ann Rheum Dis. 1999 Oct;58(10):653–654.
  13. Bouteiller G, Lloveras JJ, Condouret J, et al. [Painful polyarticular syndrome probably induced by cyclosporin in three patients with a kidney transplant and one with a heart transplant]. Rev Rhum Mal Osteoartic. 1989 Nov;56(11):753–755.
  14. Smith HS. Calcineurin as a nociceptor modulator. Pain Physician. 2009 Jul–Aug;12(4):E309–E318.
  15. Gauthier VJ, Barbosa LM. Bone pain in transplant recipients responsive to calcium channel blockers. Ann Intern Med. 1994 Dec 1;121(11):863–865.

Pages: 1 2 3 4 | Single Page

Filed Under: Conditions, Meeting Reports Tagged With: 2018 ACR/ARHP Annual Meeting, calcineurin inhibitor, calcineurin inhibitor pain syndrome, immunosuppressive drugsIssue: March 2019

You Might Also Like:
  • Cancer-Associated Myositis: A Case Report & Review of the Literature
  • Fellows’ Forum Case Report: Palmar Fasciitis & Polyarthritis Syndrome
  • Rheumatology Case Report: TINU Syndrome with Concomitant Synovitis
  • Case Report: A Patient Presents with Rare, Fulminant SAPHO Syndrome

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.